Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease

Therapeutic or Technology

Disease	Cell Type	Therapeutic or Technology	Institution	Project Objective
Autism	Adult Stem Cell	Gene-modified, donor cell therapy	UC Davis	Development Candidate, Proof of Concept
Heart Disease, Vascular Disease	iPS Cell	Small molecule therapy	Gladstone	Development Candidate
HIV/AIDS	Adult Stem Cell	Gene-modified, personalized cell therapy	CIT	Proof of Concept
Cystinosis	Adult Stem Cell	Gene-modified, personalized cell therapy	UCSD	IND
Heart disease associated with Duchenne muscular dystrophy	Adult Stem Cell	Donor cell therapy	Capricor	Clinical Trial, Phase 2
Kidney Failure	Adult Stem Cell	Biologic	Humacyte	Clinical Trial, Phase 3
Osteonecrosis	Adult Stem Cell	Personalized cell therapy	Ankasa	Pre-IND/IDE or Equivalent
Bone or Cartilage Disease	Embryonic Stem Cell	Donor cell therapy	USC	Pre-IND/IDE or Equivalent
Sickle Cell Disease	Adult Stem Cell	Gene-modified, personalized cell therapy	CHORI	Pre-IND/IDE or Equivalent
Pulmonary Hypertension, Vascular Disease	Adult Stem Cell	Donor cell therapy	Cedars-Sinai	Clinical Trial, Phase 1 or Phase 1/2
Colon Cancer	Cancer Stem Cell	Antibody	Forty Seven	Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Immune Disease	Adult Stem Cell	Gene-modified, personalized cell therapy	Stanford	Development Candidate
Type 1 diabetes	Embryonic Stem Cell	Device	UCSF	Proof of Concept
Liver Disease	Adult Stem Cell	Donor cell therapy	Stanford	Development Candidate
Huntington's Disease	Embryonic Stem Cell	Gene-modified, donor cell therapy	UC Irvine	Development Candidate, Proof of Concept
Heart Disease	Directly Reprogrammed Cell	Gene modification	Gladstone	Proof of Concept
Parkinson's Disease	iPS Cell	Gene modification	Parkinson's Institute	Development Candidate, Proof of Concept
Blood Cancer, Ovarian Cancer	iPS Cell	Donor cell therapy	UCSD	Development Candidate
Blood Disorders, Blood Cancer	Adult Stem Cell	Small molecule therapy	UCLA	Development Candidate
Diabetes	Embryonic Stem Cell	Donor cell therapy	UCSF	Development Candidate, Proof of Concept
Cystic Fibrosis	Adult Stem Cell	Gene-modified, personalized cell therapy	Stanford	Development Candidate
Neurological Disorders, Zika virus	iPS Cell	Small molecule therapy	UCSD	Development Candidate
Corneal Damage	Adult Stem Cell	Personalized cell therapy	UCLA	IND
Retinitis Pigmentosa	Adult Stem Cell	Donor cell therapy	jCyte	Clinical Trial, Phase 2
Kidney Failure	Adult Stem Cell	Donor cell therapy	Stanford	Clinical Trial, Phase 1 or Phase 1/2
Vascular Disease	Adult Stem Cell	Biologic	UCSD	Pre-IND/IDE or Equivalent
Heart Disease	iPS Cell	Assay development	Stanford	Tool/Resources/Bottleneck
Type 1 diabetes	Adult Stem Cell	Personalized cell therapy	Caladrius Biosciences	Clinical Trial, Phase 2
Amyotrophic Lateral Sclerosis	Adult Stem Cell	Gene-modified, donor cell therapy	Cedars-Sinai	Clinical Trial, Phase 1 or Phase 1/2
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID)	Adult Stem Cell	Gene-modified, personalized cell therapy	St. Jude	Clinical Trial, Phase 1 or Phase 1/2
Vision Loss	Embryonic Stem Cell	Donor cell therapy	USC	Proof of Concept, Research Insights
Heart Disease	iPS Cell	Donor cell therapy	UCSF	Proof of Concept
Muscular Dystrophy	Embryonic Stem Cell, iPS Cell	Specific Cell Type Derivation	Sanford-Burnham	Research Insights
Skeletal/Smooth Muscle disorders	Adult Stem Cell	Protein/peptide therapy	Stanford	Research Insights
B cell cancers, Leukemia	Cancer Stem Cell	Antibody	COH	Development Candidate, Proof of Concept
Parkinson's Disease	iPS Cell	Cell processing & handling	Scaled Biolabs Inc.	Development Candidate
Liver Disease	Directly Reprogrammed Cell	Gene modification	UCSF	Development Candidate
Heart Disease	iPS Cell	Model system development	UC Berkeley	Proof of Concept
Colon Cancer	Cancer Stem Cell	Small molecule therapy	COH	Development Candidate, Proof of Concept
Heart Disease	iPS Cell	Donor cell therapy	Stanford	Development Candidate, Proof of Concept
Heart Disease	iPS Cell	Personalized cell therapy	UC Davis	Proof of Concept
Blood Disorders	Adult Stem Cell	Gene-modified, personalized cell therapy	UCLA	Development Candidate, Proof of Concept
Other	Embryonic Stem Cell, iPS Cell	Cell processing & handling	X-Therma	Proof of Concept, Tool/Resources/Bottleneck
Cancer	Embryonic Stem Cell	Donor cell therapy	UCLA	Tool/Resources/Bottleneck
Huntington's Disease	Embryonic Stem Cell	Small molecule therapy	Rumi Scientific CA	Development Candidate
Neurological Disorders, Zika virus	Adult Stem Cell, iPS Cell	Vaccine	UCLA	Development Candidate
Traumatic Brain Injury	Embryonic Stem Cell	Donor cell therapy	UC Irvine	Development Candidate
Stroke	Embryonic Stem Cell	Donor cell therapy	Stanford	IND
Leukemia, Acute Myeloid (AML)	Cancer Stem Cell	Antibody	Cellerant Therapeutics, Inc.	IND
Stroke	Adult Stem Cell	Gene-modified, donor cell therapy	SanBio, Inc.	Clinical Trial, Phase 2

California's Stem Cell Agency

California Institute for Regenerative Medicine

Active Awards Portfolio Dashboard

Filter Awards

Pages

Aging
Arthritis
Blood Disorders
– Alpha Thalassemia Major
– Anemia
– Beta Thalassemia
– Bone Marrow Transplant and Viral Infection
– Hemophilia A
– Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
– Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
– Severe Combined Immunodeficiency, X-linked (X-SCID)
– Sickle Cell Disease
– X-linked Chronic Granulomatous Disease
Bone or Cartilage Disease
– Osteoarthritis
– Osteonecrosis
Cancer
– Blood Cancer
–– Acute Myeloid Leukemia
–– B cell cancers
–– HIV-related Lymphoma
–– Leukemia
–– Leukemia, Acute Myeloid (AML)
–– Multiple Myeloma
– Solid Tumors
–– Brain Cancer
–– Breast Cancer
–– Colon Cancer
–– Lung Cancer
–– Melanoma
–– Ovarian Cancer
–– Pancreatic Cancer
–– Prostate Cancer
–– Skin cancer
Developmental Disorders
Fertility
Genetic Disorder
Hearing Loss
Heart Disease
– Heart disease associated with Duchenne muscular dystrophy
– Heart failure
– Pulmonary Hypertension
Immune Disease
– Thymic Disorder, 22q11 Deletion/DiGeorge
Incontinence
Infectious Disease
– HIV/AIDS
– Zika virus
Kidney Disease
– Kidney Failure
Metabolic Disorders
– Cystinosis
– Danon Disease
– Diabetes
–– Diabetic Wounds
–– Type 1 diabetes
– Intestinal Disease
– Liver Disease
Neurological Disorders
– Alzheimer's Disease
– Amyotrophic Lateral Sclerosis
– Autism
– Canavan Disease
– Dementia
– Epilepsy
– Huntington's Disease
– Multiple Sclerosis
– Neuropathy
– Parkinson's Disease
– Rett's Syndrome
– Spina Bifida
– Spinal Cord Injury
– Spinal Muscular Atrophy
– Stroke
– Traumatic Brain Injury
Other
Pediatrics
Respiratory Disorders
– Cystic Fibrosis
– Lung Disease, Fibrosis
Skeletal/Smooth Muscle disorders
– Bladder or Urinary Tract Disorder
– Muscular Dystrophy
Skin Disease
– Epidermolysis Bullosa
Toxicity
Trauma
Vascular Disease
Vision Loss
– Age-related macular degeneration
– Corneal Damage
– Retinitis Pigmentosa

Therapeutic Approach
– Biologic
–– Antibody
–– Exosomes based therapy
–– Gene modification
–– Nucleic acid based therapy
–– Protein/peptide therapy
–– Vaccine
– Gene Therapy (All)
–– Gene Therapy, cell free
–– Gene-modified, donor cell therapy
–– Gene-modified, personalized cell therapy
– Small molecule therapy
– Device
– Donor cell therapy
– Personalized cell therapy
– Other Components
Technology
– Assay development
– Diagnostic Test
– Gene editing tools
– Cell delivery or targeting
– Cell imaging & tracking
– Cell processing & handling
– Exploring disease mechanisms
– Exploring stem cell mechanisms
– Immune tolerance/management
– Model system development
– Specific Cell Type Derivation
– Therapeutic target discovery
– Tissue engineering